Clinical Decision Support Systems Market Report | Growth Outlook 2031

Coverage: Clinical Decision Support Systems Market covers analysis By Model (Knowledge-based CDSS and Non-knowledge CDSS), Mode of Delivery (Cloud-based and On-premise), Component (Hardware, Software, and Services), Product (Integrated CDSS and Standalone CDSS), Application (Medical Diagnosis, Alerts and Reminders, Prescription Decision Support, Information Retrieval, and Other Applications) and Geography

Publication Month : Feb 2024

  • Report Code : TIPHE100001159
  • Category : Healthcare IT
  • Status : Upcoming
  • No. of Pages : 188
Inquire Before Buy

PRICING

$5190

$4671

[Research Report] The clinical decision support systems market was valued at US$ 2,120.00 million in 2022, and the clinical decision support systems market size is projected to reach US$ 3,564.00 million by 2030. It is expected to register a CAGR of 10.00% in the forecast period.

Market Insights and Analyst View:

An application that analyzes data to assist healthcare providers in making decisions and enhancing patient care is known as a clinical decision support system (CDSS). It is a variant of the decision support system (DSS), which is frequently employed to assist with the management of businesses. The main goal of a CDSS is to employ knowledge management to obtain clinical recommendations based on a variety of patient-related data elements. Clinical decision support systems facilitate integrated processes, help during patient care, and make suggestions for treatment plans. Data mining can be used with clinical decision support systems to look at a patient's medical history along with pertinent clinical studies. The results of this research can then be used to detect signs of diseases or predict possible events like drug interactions.

Computerized alerts and reminders, clinical recommendations, condition-specific order sets, patient information summaries and records, diagnostic support, documentation templates, and other pertinent reference materials are all included in CDSS solutions. Additional significant advantages provided by CDSS include better health outcomes and higher quality of care, error elimination, cost savings, enhanced productivity, and satisfaction from patients and providers.

Growth Drivers and Opportunities:

The primary drivers of the clinical decision support systems (CDSS) market's growth are the growing need to reduce healthcare costs, the requirement to improve the quality of care, and technological developments in hospital IT. In addition, the Organization for Economic Co-operation and Development (OECD) Survey Report indicates that in Germany, Norway, and Sweden, the average per capita health spending in 2021 was around USD 7,382.6, USD 7,064.8, and USD 6,262.3. Thus, it is anticipated that the high cost of healthcare would also support market expansion. The accuracy, sensitivity, and specificity measurements of the hybrid optimization learning algorithm were reported in the Science Direct study that was released in November 2022. The outcomes showed that the suggested model was consistent with previous research findings and a good fit for the diagnosis of social anxiety disorder. It is anticipated that the clinical decision support systems' efficiency will fuel market expansion.

Furthermore, the market is anticipated to develop as a result of the growing elderly population. The number of people 60 and above is predicted to rise to 1.4 billion in 2030 and 2.1 billion by 2050, according to WHO figures released in October 2022. According to a UN report from 2022, the proportion of people 65 and older is expected to increase from 10% in that year to 16% in 2050. Advanced clinical decision support systems are predicted to be in high demand due to the aging population, which is more likely to develop chronic diseases and require ongoing medical care to prevent illness will propel the market's expansion.

Furthermore, it is anticipated that growing activities such as partnerships and collaborations to create clinical decision support systems will aid in the market's expansion. For example, Google Cloud and the national hospital chain HCA Healthcare entered into a multi-year deal in June 2021 to develop personalized healthcare algorithms that will enhance clinical decision-making.

Therefore, it is anticipated that rising healthcare spending and initiatives to build clinical decision-support systems will drive market expansion. The market's growth is hampered, nevertheless, by a lack of trained personnel, suggestions from CDSS for needless diagnostic tests, and a lack of trust in the systems, given that CDSS is still in the early phases of development.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Clinical Decision Support Systems Market: Strategic Insights

clinical-decision-support-system-market
Market Size Value inUS$ 3,702.8 million in 2022
Market Size Value byUS$ 6,689.2 million by 2028
Growth rateCAGR of 10.4% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Global clinical decision support systems” are segmented based on the model, mode of delivery, component, product, application, and region. The model segment of the clinical decision support systems market is broadly segmented into knowledge-based CDSS and non-knowledge CDSS. The clinical decision support systems market is classified on the basis of mode of delivery, such as cloud-based and on-premise. The component segment of the clinical decision support systems market is broadly segmented into hardware, software, and services. Based on the product, the market is classified into integrated CDSS and standalone CDSS. On the basis of application, the clinical decision support systems market is segmented into medical diagnosis, alerts and reminders, prescription decision support, information retrieval, and other applications. The clinical decision support systems market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on the model, the clinical decision support systems market is segmented into Knowledge-based CDSS and Non-knowledge CDSS. In 2022, the Clinical Decision Support Systems market revenue was mostly attributed to the Knowledge-Based CDSS segment, which had the largest share. The Knowledge-Based CDSS's has numerous benefits. Its capacity to support physicians' clinical judgments in the face of uncertainty by applying Knowledge-Based reasoning can be attributed to the market's size and high proportion. The second fastest-growing sector in the Clinical Decision Support Systems market, non-knowledge-based CDSS, makes up a sizeable portion of the market. Non-knowledge-based CDSS still require a data source, but instead of being designed to follow expert medical knowledge, they use artificial intelligence (AI), machine learning (ML), or statistical pattern recognition to make their decisions.

Based on the mode of delivery, the clinical decision support systems market is segmented into cloud-based and on-premise. The two main factors propelling the growth of the cloud-based market segment are rising healthcare costs and cloud computing use. The governments of several European nations are launching programs to encourage the development of information technology in the medical field. For example, the UK government started a project in February 2021 to implement a fully integrated cloud-driven health service. More than two million National Health Services (NHS) emails were transferred to Microsoft's Azure Cloud as a result of this effort. Improved information availability and more seamless and effective staff communication between departments and organizations within the NHS will result from this will accelerate the expansion of the market and raise the use of (Healthcare Information Technology) HCIT Change Management services in the United Kingdom.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

On the basis of components, the clinical decision support systems market is classified into hardware, software, and services. In 2022, the services sector accounted for the majority of market revenue. The useful information base and frequent program changes are to blame for this. Maintenance services for parts and their accessories are included in CDSS services. It provides software and hardware updates, along with a knowledge library containing the most recent medications and discoveries. With the quickest rate of growth, the Clinical Decision Support Systems market is dominated by the software category. When combined with CPOE and EHR software, the CDSS software provides better decision support by creating customized and unique results for each patient.

Regional Analysis:

Based on geography, the global clinical decision support systems market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

The market for clinical decision support systems (CDSS) in North America is driven by growing patient awareness, increasing investments in healthcare IT solutions, and technological advancements in CDSS. The government's increasing support for healthcare in North America is another element contributing to the market's expansion in the US. For instance, the Congressional Budget Office (2021) reported that federal spending for the National Institute of Health (NIH) had exceeded USD 700 billion during the previous few decades.

Furthermore, the market is anticipated to develop as a result of the increasingly sophisticated products that different market competitors are likely to launch in this area. First Databank, Inc., for example, debuted the FDB CDS Analytics in August 2021 at the 2021 HIMSS Global Conference and Exhibition in Las Vegas. With the help of this technology, healthcare provider organizations may quickly locate, track, and alter clinical decision support within their EHR.

Furthermore, Pathway, a Canadian healthcare startup that provides providers with evidence-based clinical support, raised USD 1.3 million in its first financing round in June 2021. The company wanted to improve clinical decision support technologies with this funding in order to boost healthcare efficiency eventually. The above factors, which include rising investments, the introduction of CDSS, and substantial financing for healthcare, could propel the CDSS market's expansion in North America during the projected year.

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global clinical decision support systems market are listed below:

  1. In January 2023, Grand River Hospital launched Signal 1's AI-Powered Clinical Decision Support System. In order to customize and improve Signal 1's offering for Grand River Hospital's patient demographic and clinical procedures, clinical teams at the hospital worked with Signal 1 for several months prior to the product's introduction. The CAN Health Network is funding this work.
  2. In August 2022, With the launch of InterQual 2022, Change Healthcare improved clinical decision support by utilizing the most recent technology and evidence-based standards.
  3. In June 2022, The clinical decision support system was introduced by nView Health to assist in diagnosing, treating, and keeping an eye on mental disease. In order to track advancement, the nView solution employed a measurement-based care process model that included screening, evaluation, clinical follow-up and severity, and outcome monitoring.
  4. In August 2021, During the 2021 HIMSS Global Conference & Exhibition in Las Vegas, FDB, the preeminent source of drug and medical device expertise that supports healthcare professionals in making informed decisions, introduced FDB CDS Analytics. In order to improve patient outcomes, the solution helps healthcare provider organizations identify, track, and customize clinical decision support (CDS) in their electronic health record (EHR). This, in turn, improves clinician user experiences and advances CDS impact across all care areas.
  5. In June 2021, The white paper Clinical Decision Support: Leveraging Technology to Drive Outcomes and Efficiencies was launched today by Altera Digital Health, Inc. and the American Health Information Management Association (AHIMA). Faster decision-making, more efficiency, and better patient outcomes were reported by a panel of doctors and health information specialists who discussed the effects of enhanced clinical decision support (CDS) on clinical workflow and satisfaction.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global clinical decision support systems market are Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., IBM Corporation, Relx Group Plc, Mckesson Corporation, General Electric Company, Siemens AG, Meditech, Zynx Health and amongst others. These clinical decision support systems market focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share. The report offers clinical decision support systems market trends analysis emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Component, Delivery Mode, Application, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies -  clinical decision support systems market

  1. Cerner Corporation
  2. Medical Information Technology, Inc.
  3. BD
  4. Wolters Kluwer N.V.
  5. Baxter International Inc.
  6. Premier
  7. Koninklijke Philips N.V.
  8. RELX (Elseiver)
  9. PeraHealth
  10. Epic Systems Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Clinical Decision Support Systems Market